Every SEC Form 3/4/5 on record for this filer (CIK 1734779) — 5 issuers, 43 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PCRX | Pacira BioSciences, Inc. | Chief Financial Officer | 2024-10-23 → 2026-04-24 | 8 | −$2M |
| CYTH | Cyclo Therapeutics, Inc. | Director | 2023-12-28 → 2025-03-03 | 6 | — |
| AMTI | Applied Molecular Transport Inc. | CEO & Chair of the Board · Director · lapsed | 2020-06-04 → 2023-12-28 | 16 | −$383,340 |
| BIOS | BioPlus Acquisition Corp. | Director · lapsed | 2021-12-02 → 2021-12-02 | 1 | — |
| GTBP | GT Biopharma, Inc. | Chief Executive Officer · Director · lapsed | 2018-03-16 → 2018-03-16 | 1 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PCRX | 2026-04-23 | Sell | 12,941 | $25.16 | $325,596 | 105,341 |
| PCRX | 2026-04-22 | Sell | 1,500 | $25.01 | $37,515 | 105,341 |
| PCRX | 2026-04-21 | Sell | 2,845 | $25.01 | $71,153 | 105,341 |
| PCRX | 2026-04-20 | Sell | 7,714 | $25.14 | $193,930 | 105,341 |
| PCRX | 2025-12-10 | Sell | 9,104 | $25.14 | $228,875 | 56,250 |
2 of 5 issuers are covered and open a security page; the rest are on file here only.
